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Summary 
Tissue eosinophilia is a characteristic feature of a number of inflammatory diseases including 
asthma and nasal polyposis. Eosinophil migration into tissues is controlled in part by interactions 
between eosinophil adhesion receptors and counter-structures on the vascular endothelium. To 
determine  the  receptors used by  eosinophils  to  adhere  to  vascular  endothelium in  allergic 
inflammation we have adapted the Stamper-Woodruff  frozen section assay (FSA) to study eosinophil 
adhesion to nasal  polyp endothelium.  Immunohistology indicated that intercellular adhesion 
molecule I (ICAM-1), E-selectin and P-selectin were well expressed by nasal polyp endothelium, 
whereas  expression  of vascular  cell  adhesion  molecule  1  (VCAM-1)  was  weak  or  absent. 
Unstimulated human peripheral blood eosinophils  adhered specifically to nasal polyp endothelium. 
Adherence was temperature and divalent cation-dependent and saturable at cell densities >5  x 
106 cells/ml. Eosinophil adhesion was almost completely inhibited by a monoclonal antibody 
(mAb) against P-selectin and by a chimeric molecule consisting of the Fc portion of human IgG 
and the lectin binding domain of P-selectin, which binds  to the P-selectin ligand on leuco- 
cytes. Anti-Mac-1 mAb partially inhibited eosinophil adhesion whereas mAb against E-selectin, 
L-selectin, ICAM-1, VCAM-1, very late activation antigen 4, and lymphocyte function-associated 
antigen 1 had no effect. P-selectin is stored in intracellular granules within the endothelial cell 
and in vitro is only transiently expressed. To determine if P-selectin was expressed on the membrane 
of the nasal polyp endothelium we compared P-selectin expression in normal skin and nasal polyps 
after acetone fixation, which permeabilizes cells, and paraformaldehyde, which only allows staining 
of membrane expressed receptors. In the skin, good expression was seen with acetone fixation 
but no expression was seen after paraformaldehyde treatment, whereas in nasal polyps, similar 
expression was observed with both fixatives.  In addition immunoftuorescence with confocal 
microscopy demonstrated lumenal staining of nasal polyp endothelium indicating that P-selectin 
was located on the surface of endothelial cells while in skin only an intracellular granular distribution 
was apparent.  Lastly, whereas eosinophils bound consistently to nasal polyp endothelium, no 
binding was observed to blood vessels in normal skin further supporting the idea that eosinophils 
were binding to membrane expressed and not intracellular P-selectin.  The importance of P-selectin 
in eosinophil adhesion to nasal polyp endothelium suggests that P-selectin antagonists may be 
effective at inhibiting eosinophil accumulation at sites of allergic inflammation. 
A 
consistent feature of asthma and related diseases  such 
as allergic rhinitis and atopic dermatitis is infiltration 
of the tissue by eosinophils (1, 2). Eosinophil accumulation 
in these diseases is relatively selective in that it generally occurs 
without an increase in neutrophils, although increased numbers 
of T  cells and monocytes are often seen.  One explanation 
for the specific  tissue migration of eosinophils in allergic 
inflammation is a selective pathway of eosinophil adhesion 
and transmigration.  One such potential pathway uses very 
late activation antigen 4  (VLA-4),  a receptor expressed by 
eosinophils but not neutrophils, binding to vascular cell adhe- 
sion molecule 1 (VCAM-1) on endothelium (3-6). Evidence 
for the importance of this pathway in eosinophil migration 
was provided by the selective increase in VCAM-1 expres- 
sion  on  cultured  human  umbilical  vein  endothelial  cells 
(HUVEC) induced by IL-4 (7). IL-4, which is generated in 
asthmatic airways,  also mediated eosinophil transmigration 
through HUVEC in a VLA-4/VCAM-l-dependent fashion 
and IL-4 transgenic mice had an eosinophilic conjunctivitis 
(8, 9). In contrast VCAM-1 was weakly expressed in chronic 
371  J. Exp. Med. ￿9  The Rockefeller  University  Press ￿9 0022-1007/94/07/0371/06 $2.00 
Volume 180  July 1994  371-376 asthmatic airways with no evidence of a difference in expres- 
sion between normal and diseased tissue (10). Further studies 
have revealed  few other major differences  in the profile of 
adhesion receptors expressed by eosinophils compared with 
other leukocytes. They express L-selectin, which is shed on 
cell activation, and functional ligands for E-selectin and P-sel- 
ectin (11-13). Their expression of leukocyte integrins is similar 
to that of neutrophils (14), and like neutrophils, eosinophil 
adhesion to HUVEC can be inhibited by blocking antibodies 
against LFA-1,  Mac-l, and intercellular adhesion molecule 
1 (ICAM-1) (15). Despite the relative lack of selectivity in 
the expression of adhesion receptors on eosinophils compared 
with other leukocytes it remains possible that there are func- 
tional differences in adhesion receptor usage. In addition, the 
pattern of adhesion receptor expression on HUVEC may not 
reflect the expression of adhesion receptors in vivo in allergic 
inflammation. To determine the adhesion receptors  used by 
eosinophils to adhere to airway endothelium we have adapted 
the frozen section assay (FSA),  first  used by Stamper and 
Woodruff  (16) to study lymphocyte homing to lymph nodes, 
to investigate eosinophil adhesion to nasal polyp endothelium. 
We have shown that adhesion of unstimulated eosinophils 
to nasal polyp endothelium is primarily mediated by P-selectin. 
Materials  and Methods 
Reagents.  Control mouse myeloma proteins MOPC  (IgG1, 
IgG2a, and IgG2b, mixed in equal proportions), human IgG, and 
FITC-labeled goat anti-mouse  IgG Fc F(ab)2 fragments, (Sigma 
Chemical Co., Poole, UK). Micromagnetic beads bound to anti- 
CD16 mAb and magnetic-activated cell sorter (MACS) columns, 
(Eurogenetics, Teddington, UK). The P-selectin-IgG  chimeric  mol- 
ecule consists of the lectin and epidermal growth factor-binding 
domains  and one complement  binding protein-like  domain of  human 
P-selectin engineered to the human IgG1 Fc portion. The chimera 
is known to bind to the human P-selectin  ligand (17) and was found 
to bind to human eosinophils by FACS  |  analysis (Becton Dick- 
inson & Co., Oxford,  UK).  Binding was cation dependent and 
independent of the activation status of the eosinophils (data not 
shown). 
Antibodies.  The mouse mAb listed below were used in adhe- 
sion blockade studies and were received as kind gifts from the fol- 
lowing groups: IF-11 (anti-E-selectin,), 11C8-I (anti-ICAM-1), and 
4B2 (anti-VCAM-1) from Dr. L. Needham (British Biotechnology, 
Oxford, UK); HP1/2 (anti-VLA-4) from Dr. F. Sanchez-Madrid 
(Hospital de la Princesa, Madrid, Spain); TSI/22 (anti-LFA-1)  from 
Dr. T. Springer (Dana Farber Cancer Institute, Boston, MA); G1 
(anti-P-selectin) from Dr. R. McEver (Oklahoma Medical  Research 
Foundation, Oklahoma City, OK); Dreg 56 (anti-L-selectin)  from 
Dr. K. Kishimoto (Boehringer Ingelheim, Ridgefield, CT). The 
anti-Mac-1 mAb was purchased  from Dako (M741 Clone 2LPM19C; 
High Wycombe, UK); anti-CD18 mAb from British Biotechnology 
(Oxford, UK, BCA5 Clone MEM48) and Leu 8 (anti-L-selectin) 
was purchased from Becton Dickinson & Co. Leu 8 was used to 
confirm expression of  bselectin by eosinophils and in initial inhibi- 
tion experiments. As the manufacturer could not confirm the ability 
ofLeu 8 to block L-selectin  activity  we changed to Dreg 56, a known 
blocking mAb. No inhibition of adhesion was seen using either 
antibody. For immunohistochemical  staining of tissue sections: we 
used mAbs RUU-SPI.18 (anti-P-selectin)  from Dr. H. K. Nieuwen- 
huis and Dr. M.J. Metzelaar (University  Hospital Utrecht, Utrecht, 
Netherlands); 140-13 (anti-CD41, a platelet specific  marker) from 
Dr.  R.  Vilella (Hospital  Clinic,  Barcelona, Spain); BMK-13 
(anti-human eosinophil major basic protein) from Dr. R. Moqbel 
(National Heart and Lung Institute, London, UK). BBA-1 (anti- 
E-selectin), BBA-3 (anti-ICAM-1) and BBA-5 (anti-VCAM-1) were 
purchased from British Biotechnology and EN4 (antiendothelial 
cell) was obtained from Bradsure Biologicals  (Loughborough, UK). 
All mAbs were used as whole molecules rather than F(ab)2 frag- 
ments as freshly isolated eosinophils do not express high affinity 
Fc receptors and previous studies have indicated no interference  by 
Ig Fc in eosinophil-endothelial cell interactions (6,  18). 
Tissue.  Nasal  polyps (n =  8) were obtained after routine sur- 
gery in the Ear, Nose, and Throat Department  (Leicester Royal 
Infirmary). Patients were aged 19-84. Two patients were taking 
nasal steroids. Nasal polyps were received  within 0.5 h of removal, 
washed briefly in PBS, dissected, and snap frozen in liquid N2. The 
highly eosinophilic nature of the polyps was confirmed by immu- 
nostaining for eosinophil major basic protein (MBP). Skin tissue 
from breast, removed during mastectomy (n  =  2), and forearm, 
isolated by punch biopsy (n  =  1), were snap frozen immediately 
upon receipt. All tissue samples were stored in vapor phase liquid 
N2 until required. 
Eosinophil Purification.  Eosinophils were isolated from 100 ml 
of blood from healthy volunteers with no clinical evidence of al- 
lergic symptoms at the time of venesection and eosinophil counts 
of <0.4  x  106/ml. After dextran sedimentation leukocytes were 
subjected to a slow spin (200g) to remove  platelets before centrifu- 
gation (Histopaque 1083; Sigma Chemical Co.) (400g, for 25 min, 
at room temperature [RT]). Eosinophils were isolated by negative 
immunomagnetic selection  using CD16 Microbeads and the MACS 
system (19). Isolates consisting of >99% eosinophils, with viabili- 
ties of >95%, as judged by trypan blue exclusion, were routinely 
obtained. Eosinophils  were occasionally  used after storage overnight 
at 4~  in assay medium (medium 199 with Earle's salts, L-GIn, 
Hepes plus 2% FCS) and EGTA. No difference  in adherence was 
found between stored and fresh cells. Eosinophils did not express 
the platelet adhesion receptor IIb/IIIa demonstrating that there 
was no platelet contamination. 
FSA.  The frozen section assay  was adapted from the method 
of Stamper and Woodruff (16). Briefly, 100 #1  of eosinophils 
(5 x l& cells/ml) in assay medium _+  EGTA, were pipetted over 
8/~m nasal polyp sections, on silane  coated microscope  slides. Slides 
were rotated at 70 rpm for 30 min at RT on a rotating platform. 
Unbound cells  were gently tipped offbefore fixing in 2% glutaralde- 
hyde in PBS for 30 rain. Slides were washed for 10 min in PBS, 
with rotation, before staining using May Grunwald/Giemsa. Eo- 
sinophil adhesion  was assessed  visually,  on blinded  slides,  by counting 
the number of blood vessels that bound two or more eosinophils 
from 100 vessels  located  randomly within each section and expressed 
as the percent of  blood vessels which bound eosinophils. Each assay 
was carried out at least in duplicate. The intraassay coefficient  of 
variation was 9.2%. 
Immunohistology.  Nasal  polyps (8 patients) and skin (n  =  3) 
were examined. 6-/~m sections were air dried, fixed in either ace- 
tone (100%, 10 rain at RT) or paraformaldehyde  (4% freshly pre- 
pared, ice cold paraformaldehyde,  5 min at RT), and then immuno- 
stained using the streptavidin-biotin (ABC), alkaline phosphatase 
method, as recommended  by the manufacturer  (Dako). The number 
of blood vessels staining positive for each adhesion receptor mAb 
was expressed as the percent of total blood vessels, as estimated 
by positive staining with the endothelial-specific  mAb, EN4. 
lmmunofluorescence.  8-~m frozen sections were fixed in acetone 
before indirect immunofluorescence  staining for P-selectin (RUU- 
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lyzed using  a  confocal microscope (model MRC  600;  Bio-Rad 
Laboratories,  Richmond,  CA). 
Statistics.  Significance was determined using an unpaired stu- 
dent's t test. Data is quoted as the mean  _+  SEM, with/~ ~<0.05 
being considered significant. 
Results and Discussion 
Under  the  conditions  of the  FSA  eosinophils  adhered 
specifically to nasal polyp endothelium with minimal adhe- 
sion to other structures within  the section (Fig.  1 A).  Al- 
though two adherent eosinophils were taken as the minimum 
to record a positive blood vessel, most positive vessels had 
considerably more bound cells.  Adhesion was  almost  com- 
pletely abolished by treating either the section or the eosino- 
phils with EGTA, indicating cation dependence and suggesting 
that adhesion was mediated by specific receptors (Fig. 1 B). 
Adhesion was dependent on eosinophil concentration, being 
undetectable below 10  s ceUs/ml and maximal (48.9  _+  5.3% 
positive  blood  vessels)  at  0.5-1  x  107  cells/ml  (n  =  3). 
Above 107 cells/ml, marked adhesion throughout the section 
was observed. Adhesion was temperature dependent, increasing 
from 26.6  +  1.6%  positive blood vessels at 4~  to an op- 
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Figure  2.  Inhibition of eosin- 
ophil  adhesion  to  nasal polyp 
endothelium  by  mAbs against 
endothelial adhesion molecules. 
Nasal polyp sections were incu- 
bated for  30  min  at  RT  with 
mAb against various endothelial 
adhesion  molecules before the 
FSA.  Eosinophil adhesion was 
inhibited  either  by  the  anti- 
P-selectin mAb, G1,  or  treat- 
ment of eosinophils  with EGTA, 
(p <0.0005), compared  with an isotype matched IgG control, but not by 
mAbs against E-selectin (IF-11), ICAM-1 (11C8-I), or VCAM-1 (4B2) 
(n = 9). Experiments  were carried  out on nasal polyps  from three patients. 
timum of 43.3  _+  3.5%  at 24~  and falling back to 32.7 
+  3.1% at 37~  (n  =  3). All further experiments were there- 
fore carried out at RT with a cell concentration of 5  x  106 
cells/ml. 
To determine which receptors were mediating eosinophil 
adhesion we first investigated the expression of adhesion mol- 
ecules by nasal polyp endothelium. ICAM-1 (40%), E-selectin 
(29%),  and P-selectin (45%) were well expressed in all the 
polyps  studied.  Figures  in brackets  refer to  the mean per- 
centage of total blood vessels that stained positive in sections 
from eight polyps.  P- and E-selectin staining  was confined 
to the endothelium whereas ICAM-1 was also expressed on 
tissue leukocytes and the epithelium. In contrast, expression 
of VCAM-1  (5%)  was  either  absent  or very weak. 
We than investigated the inhibitory effects of  blocking mAbs 
against both endothelial  and eosinophil adhesion receptors. 
Of the endothelial receptors a mAb  against  P-selectin (G1) 
almost  completely  inhibited  eosinophil  adhesion  to  nasal 
polyp endothelium (p <0.0005). Blocking antibodies against 
E-selectin, ICAM-1 and VCAM-1 had no effect (Fig. 2). Of 
the antibodies directed against eosinophil adhesion receptors 
only a mAb  directed against  the ot chain of Mac-1  caused 
significant inhibition and this was modest in degree. Anti- 
bodies against L-selectin, the c~ and fl chains of LFA-1, and 
the c~ chain of VLA-4 had no effect. In contrast, a P-selectin 
chimeric  molecule  almost  completely inhibited  eosinophil 
adhesion, whereas control human IgG had no effect (Fig. 3). 
Figure 1.  Eosinophil  adhesion to nasal polyp endothelium in the ab- 
sence (A) or presence (B) of EGTA. Eosinophils (5  x  106 cells/ml) were 
washed and resuspended in assay medium _+ EGTA before layering over 
nasal polyp sections  in the FSA. Adherent eosinophils are indicated  by the 
arrows. 
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Figure  3.  Inhibition ofeosin- 
ophil  adhesion  to  nasal polyp 
endothelium  by  mAbs against 
eosinophil  adhesion molecules. 
Eosinophils were  incubated  at 
RT for 10 min with mAb against 
eosinophil  adhesion  molecules, 
isotype  matched IgG  controls 
or EGTA-treated assay medium, 
before FSA. Eosinophil adhesion 
was inhibited  by the P-selectin  chi- 
mera, which binds the P-selectin 
ligand,  EGTA (p <0.0005) and 
by an anti-CD11b mAb (M741) (p <0.005). Antibodies against VLA-4 
(HP1/2), CDlla (TSI/22), CD18 (BCAS), and L-selectin  (Leu  8 and Dreg 
56) had no effect (n  =  7). Experiments were carried out on nasal polyps 
from four patients. 
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dothelial cells (20). To exclude the possibility that eosinophils 
were binding to intracellular P-selectin we compared P-selectin 
expression and eosinophil binding to the endothelium of nasal 
polyps and normal skin. In acetone-fixed tissue the percentage 
of blood vessels that expressed P-selectin was similar in skin 
and nasal polyps. However eosinophils bound avidly to nasal 
polyp endothelium, whereas virtually no binding to skin blood 
vessels was observed, suggesting that in skin, P-selectin was 
intracellular and not available for interaction with eosino- 
phils (Table 1). When paraformaldehyde, which does not per- 
meabilize cell membranes, was substituted for acetone,  no 
P-selectin expression was  seen  in  skin (Fig.  4, A  and B), 
whereas good expression was seen in nasal polyps with both 
fixatives  (Fig.  4,  C  and D).  This further suggests that en- 
dothelial P-selectin in skin is intracellular, whereas in nasal 
polyps it is also expressed  on the cell  surface.  The pattern 
observed with immunofluorescence staining and confocal mi- 
croscopy also supported this idea in that membrane staining 
could be clearly seen on nasal polyp endothelium (Fig. 4 E) 
whereas in the skin a more granular pattern was observed 
consistent with staining of intracellular P-selectin  stored in 
Weibel-Palade  bodies (Fig.  4 F). 
There is  good evidence  that  migration of granulocytes 
through endothelium is a staged process involving an initial, 
selectin-mediated stage, which occurs under flow conditions, 
followed by cell activation, which allows transmigration medi- 
ated by integrin/immunoglobulin family adhesion receptor 
interactions (21). The conditions of our assay, using unstimu- 
lated eosinophils from normal donors, at RT, and rotating 
the eosinophils over the frozen sections to create a degree 
of shear stress,  favors a selectin-mediated interaction. This 
may explain why antibodies against ICAM-1 and the leuko- 
cyte integrins were largely ineffective despite these molecules 
playing a  part  in  eosinophil migration  through  cultured 
HUVEC. We did see a small but significant inhibitory effect 
with a mAb against the ee, but not the 3  chain of Mac-1. 
The reason for this discrepancy is not clear as both mAbs 
block Mac-l-dependent functions. Mac-1 can bind ICAM-1 
through a site distinct from LFA-1 (22) and it is possible that 
the antibody we used does not block Mac-1/ICAM-1 inter- 
actions. Alternatively there may be another, as yet unidentified, 
Table  1.  Comparison of P-selectin Expression and Eosinophil 
Adherence to Skin  and Nasal Polyp  Tissue 
Tissue 
Percent of total blood 
vessels that are 
P-selectin positive 
Percent of total blood 
vessels that bound 
eosinophils 
Skin  50.0  _+  4.82  1.80  _+  0.69 
Nasal polyp  58.9  •  4.39  25.1  _+  4.37 
Results were from a single  experiment on four consecutive  sections and 
are representative of two other experiments using tissue from different 
donors. 
Figure  4.  Cellular  location of P-selectin in nasal polyp and skin en- 
dothelial  cells. Immunohistochemical  staining  of tissue  endothelium  using 
the mAb RUU-SPI.18, on acetone fixed skin (A) and nasal polyp (C) 
and paraformaldehyde-fixed  skin (B) and nasal polyp  (D) tissue sections. 
Tissue sections were sequential so that the same blood vessels could  be 
observed with each  fixative.  P-selectin  staining  was apparent on both ace- 
tone fixed  nasal  polyp  and skin  endothelium  but only  on nasal  polyp  blood 
vessels when  sections  were  fixed  using  paraformaldehyde.  Immunofluores- 
cence staining  of tissue endothelium  for P-selectin and confocal  micros- 
copy, as indicated  in Materials  and Methods, showed  lumenal  staining  of 
nasal polyp endothelium (arrow) (E) and granular staining of skin en- 
dothelium (arrow) (F). 
ligand for Mac-1 expressed on nasal polyp endothelium. An 
antibody against  VLA-4  was  also  ineffective  presumably 
because  of the lack of expression  of its endothelial ligand 
VCAM-1, which does not appear to have a major role to play 
in established  allergic  inflammation. 
In vitro studies have demonstrated that eosinophils can 
potentially use all three selectins;  however,  our study raises 
the possibility that in vivo P-selectin plays a dominant role 
in mediating the selectin stage of eosinophil adhesion. This 
would also suggest that in the case of eosinophils P-selectin 
is not a physiological ligand for L-selectin (23).  Neutrophil 
adhesion both in vitro and in vivo has been shown to be in- 
hibited by antibodies against all three selectins (24-27).  In 
the case of E-selectin  a blocking mAb inhibited the influx 
of neutrophils,  but  not  eosinophils,  into  the  airways  of 
cyanomologous monkeys after challenge with ascaris antigen 
(28).  This raises the exciting possibility that P-selectin an- 
tagonists may abolish eosinophil migration into tissue without 
374  Eosinophil  Adhesion to Nasal Polyp Endothelium  Is P-Selectin-dependent completely blocking neutrophil migration and therefore act 
as a relatively selective inhibitor  of eosinophil  migration. 
In vitro evidence with cultured HUVEC has demonstrated 
that P-selectin is rapidly and transiently mobilized to the cell 
surface over the course of ~0.5 h (29). It has therefore been 
generally considered that P-selectin's major role is restricted 
to directing the initial influx of neutrophils during the acute 
inflammatory response. We were therefore concerned either 
that  eosinophils were binding  to intracellular  P-selectin or 
that P-selectin was mobilized to the cell surface during the 
processing of the nasal  polyps.  The  pattern  of staining  of 
P-selectin on nasal polyp endothelium compared with skin 
strongly suggested that, in normal skin P-selectin was intra- 
cellular,  while in polyps it was expressed on the cell mem- 
brane. Moreover, P-selectin on nasal polyp endothelium was 
capable of supporting eosinophil adhesion, whereas P-selectin 
in skin did not, suggesting both that P-selectin is not mobi- 
lized to the cell surface during procedures such as polypec- 
tomy or skin removal (both equally traumatic and involving 
a general anaesthetic)  and that  intracellular  P-selectin does 
not support eosinophil adhesion in this assay. It is possible 
that eosinophils adhered to nasal polyps but not skin because 
an additional ligand was involved which was not expressed 
in skin. We feel this unlikely as antibodies against the major 
known eosinophil adhesion receptors had no effect and eo- 
sinophils can bind readily to P-selectin-coated plates (14). In- 
dependent of our study, although  using a similar strategy, 
Grober et al. recently reported that P-selectin was constitu- 
tively expressed on the membrane  of the synovial vascular 
endothelium in rheumatoid arthritis and that monocyte adhe- 
sion  to  synovium had  a large  P-selectin component  (30). 
P-selectin is expressed by platelets and a further concern was 
that platelets either in the tissue or adhering to eosinophils 
could be involved in some way. However our eosinophil sepa- 
ration technique avoids platelet contamination and virtually 
no platelets were seen in the nasal  polyp section either by 
routine histology or after immunostaining using mAb 140- 
13 directed against platelet gplIb/IIIa  (data not  shown). 
Thus, in summary, using a modification of the Stamper- 
Woodruff FSA, we have demonstrated that unstimulated pe- 
ripheral blood eosinophils adhered specifically to nasal polyp 
endothelium, primarily using the endothelial  adhesion receptor 
P-selectin, binding to an as yet unidentified counter-receptor 
on eosinophils. This suggests that P-selectin, possibly induced 
by mast cell and basophil derived mediators  such as hista- 
mine or Th2-derived cytokines, has an important role to play 
in directing eosinophil migration to sites of chronic eosino- 
philic inflammation  and that P-selectin antagonists  may be 
effective in  the treatment  of allergic disease. 
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